Parkinson’s Disease and Photobiomodulation: Potential for Treatment
Parkinson’s disease is the second most common neurodegenerative disease and is increasing in incidence. The combination of motor and non-motor symptoms makes this a devastating disease for people with Parkinson’s disease and their care givers. Parkinson’s disease is characterised by mitochondrial dy...
Main Authors: | Brian Bicknell, Ann Liebert, Geoffrey Herkes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/14/1/112 |
Similar Items
-
A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes
by: Claire McGee, et al.
Published: (2023-04-01) -
Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy to patients with Parkinson’s disease
by: Claire McGee, et al.
Published: (2022-08-01) -
A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility studyResearch in context
by: Geoffrey Herkes, et al.
Published: (2023-12-01) -
Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study
by: Brian Bicknell, et al.
Published: (2022-01-01) -
Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study
by: Ann Liebert, et al.
Published: (2021-07-01)